ECM
CTIC

ExodusPoint Capital Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

ExodusPoint Capital Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-952,343
Closed -$4M – 2385
2023
Q1 		$4M Buy
952,343
+643,530
+208% +$3.34M 0.05% 592
2022
Q4 		$1.86M Buy
+308,813
New +$1.69M 0.03% 678
2022
Q2 		– Sell
-80,916
Closed -$378K – 2782
2022
Q1 		$378K Buy
+80,916
New +$241K 0.01% 1671
2021
Q2 		– Sell
-189,516
Closed -$551K – 3088
2021
Q1 		$551K Sell
189,516
-46,301
-20% -$151K 0.01% 1278
2020
Q4 		$759K Buy
+235,817
New +$784K 0.01% 1007

Other funds holding CTIC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return